Characteristics and treatment patterns among patients with HER2-amplified advanced/metastatic colorectal cancer (mCRC): A clinical-genomic database study

被引：2
|
作者：
Strickler, J. H. [1 ]
Hsu, L-I. [2 ]
DeBusk, K. [2 ]
Wright, P. [2 ]
Stecher, M. [3 ]
Siadak, M. [4 ]
Palanca-Wessels, M. C. [3 ]
Yu, J. [5 ]
Zhang, N. [6 ]
Espenschied, C. R. [7 ]
Lang, K. [6 ]
Bekaii-Saab, T. [8 ]
机构：
[1] Duke Canc Ctr, Div Med Oncol, Durham, NC USA
[2] Seagen Inc, Global Hlth Econ & Outcomes Res, Bothell, WA USA
[3] Seagen Inc, Clin Dev, Bothell, WA USA
[4] Seagen Inc, Med Affairs, Bothell, WA USA
[5] Guardant Hlth Inc, Clin Dev, Redwood City, CA USA
[6] Guardant Hlth Inc, Outcomes & Evidence, Redwood City, CA USA
[7] Guardant Hlth Inc, Med Affairs, Redwood City, CA USA
[8] Mayo Clin, Div Hematol Oncol, Phoenix, AZ USA
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.960
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
439P
引用
收藏
页码：S554 / S554
页数：1
相关论文
共 50 条
  • [21] Patterns of Referral and Resection Among Patients with Liver-Only Metastatic Colorectal Cancer (MCRC)
    Ksienski, Doran
    Woods, Ryan
    Speers, Caroline
    Kennecke, Hagen
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (12) : 3085 - 3093
  • [22] Trastuzumab plus pertuzumab for HER2-amplified advanced colorectal cancer: Results from the drug rediscovery protocol (DRUP)
    Spiekman, Ilse A. C.
    Zeverijn, Laurien J.
    Geurts, Birgit S.
    Verkerk, Karlijn
    Mohammad, Soemeya F. Haj
    Noort, Vincent van der
    Roepman, Paul
    Leng, Wendy W. J. de
    Jansen, Anne M. L.
    Gootjes, Elske C.
    Groot, Derk-Jan A. de
    Kerver, Emile D.
    van Voorthuizen, Theo
    Roodhart, Jeanine M. L.
    Iersel, Liselot B. J. Valkenburg-van
    Gelderblom, Hans
    Voest, Emile E.
    Verheul, Henk M. W.
    EUROPEAN JOURNAL OF CANCER, 2024, 202
  • [23] Patterns of Referral and Resection Among Patients with Liver-Only Metastatic Colorectal Cancer (MCRC)
    Doran Ksienski
    Ryan Woods
    Caroline Speers
    Hagen Kennecke
    Annals of Surgical Oncology, 2010, 17 : 3085 - 3093
  • [24] Trastuzumab use in patients with durable complete response in HER2-amplified metastatic breast cancer: to continue or not to continue
    Butterbaugh, S. T.
    Patel, R.
    Romond, E. H.
    Mathew, A.
    ANNALS OF ONCOLOGY, 2017, 28 (12) : 3098 - 3099
  • [25] HER2-targeted therapy should be shifted towards an earlier line for patients with anti-EGFR-therapy naive, HER2-amplified metastatic colorectal cancer
    Nakamura, Yoshiaki
    Sawada, Kentaro
    Fujii, Satoshi
    Yoshino, Takayuki
    ESMO OPEN, 2019, 4 (03)
  • [26] Impact of baseline alterations in HER2-pathway oncogenic drivers on response to anti-HER2 therapy in patients (pts) with HER2-amplified advanced colorectal cancer (aCRC).
    Hoyek, Celine
    Pirozzi, Angelo
    Zheng-Lin, Binbin
    Abidoye, Oluseyi
    Eslinger, Cody
    Nakamura, Yoshiaki
    Ramaker, Ryne
    Sonbol, Mohamad Bassam
    Wu, Christina
    Borad, Mitesh J.
    Ahn, Daniel H.
    Ikeda, Masafumi
    Shibuki, Taro
    Yoshino, Takayuki
    Strickler, John H.
    Bekaii-Saab, Tanios S.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 243 - 243
  • [27] Safety and efficacy of bevacizumab and systemic therapy in metastatic colorectal cancer (mCRC) patients with peritoneal disease in the Treatment of Recurrent and Advanced Colorectal Cancer (TRACC) database.
    Roohullah, Aflah
    Wong, Hui-li
    Sjoquist, Katrin Marie
    Field, Kathryn Maree
    Tran, Ben
    Shapiro, Jeremy David
    McKendrick, Joseph James
    Yip, Desmond
    Nott, Louise M.
    Gibbs, Peter
    Chantrill, Lorraine A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [28] TREATMENT PATTERNS AND OUTCOMES IN METASTATIC COLORECTAL CANCER (MCRC) PATIENTS TREATED IN A COMMUNITY ONCOLOGY SETTING
    Cartwright, T. H.
    Pan, I
    Wen, L.
    Wadlow, R. C.
    Rembert, D.
    Seal, B.
    VALUE IN HEALTH, 2014, 17 (03) : A69 - A70
  • [29] Patient characteristics and treatment patterns of patients with locally advanced or metastatic HER2-low breast cancer, a single site descriptive study
    Willis, Connor
    Tan, Chia Jie
    Chhibber, Anindit
    Watanabe, Alexandre H.
    Lam, Clara
    Mehta, Sandhya
    Kwong, Jackie
    Park, Leah
    Pavilack-Kirker, Melissa
    Xu, Xiaoqing
    Kelley, Kristen
    Stenehjem, David
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 208 (03) : 619 - 630
  • [30] Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I study in patients with metastatic HER2-amplified breast cancer.
    Gajria, D.
    King, T. A.
    Pannu, H.
    Sakr, R.
    Seidman, A. D.
    Syldor, A.
    Patil, S.
    Maybody, M.
    Norton, L.
    Rosen, N.
    Hudis, C.
    Chandarlapaty, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345